Skip to content
10-Q

Quarterly Report

ENDRA Life Sciences Inc. NDRA

0001654954-25-009643

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 14, 2025 752.76K sh
Capex Q2 2025 · Jun 30, 2025 $17.28K
Capex Q2 2025 · Jun 30, 2024 $16K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$2.41M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$4.23M
Stockholders Equity Q2 2025 · Jun 30, 2025 $1.47M
Stockholders Equity Q2 2025 · Mar 31, 2025 $1.75M
Stockholders Equity Q2 2025 · Dec 31, 2024 $2.56M
Stockholders Equity Q2 2025 · Jun 30, 2024 $8.99M
Stockholders Equity Q2 2025 · Mar 31, 2024 $3.7M
Stockholders Equity Q2 2025 · Dec 31, 2023 $5.66M
Current Liabilities Q2 2025 · Jun 30, 2025 $576.64K
Current Liabilities Q2 2025 · Dec 31, 2024 $605.23K
Total Liabilities Q2 2025 · Jun 30, 2025 $1.33M
Total Liabilities Q2 2025 · Dec 31, 2024 $1.89M
Current Assets Q2 2025 · Jun 30, 2025 $1.85M
Current Assets Q2 2025 · Dec 31, 2024 $3.43M
Total Assets Q2 2025 · Jun 30, 2025 $2.81M
Total Assets Q2 2025 · Dec 31, 2024 $4.45M
Sga Expense Q2 2025 · Jun 30, 2025 $851.2K
Sga Expense Q2 2025 · Jun 30, 2025 $1.72M
Sga Expense Q2 2025 · Jun 30, 2024 $1.35M
Sga Expense Q2 2025 · Jun 30, 2024 $2.85M
Rd Expense Q2 2025 · Jun 30, 2025 $381.06K
Rd Expense Q2 2025 · Jun 30, 2025 $909.75K
Rd Expense Q2 2025 · Jun 30, 2024 $716.37K
Rd Expense Q2 2025 · Jun 30, 2024 $1.76M
Net Income Q2 2025 · Jun 30, 2025 −$1.23M
Net Income Q2 2025 · Jun 30, 2025 −$2.26M
Net Income Q2 2025 · Jun 30, 2024 −$2.23M
Net Income Q2 2025 · Jun 30, 2024 −$5M
Operating Income Q2 2025 · Jun 30, 2025 −$1.3M
Operating Income Q2 2025 · Jun 30, 2025 −$2.77M
Operating Income Q2 2025 · Jun 30, 2024 −$2.23M
Operating Income Q2 2025 · Jun 30, 2024 −$5.01M